Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Oncolines offers cell toxicity as an alternative readout for 102 cancer cell panel profiling studies
Oncolines® profiling is the parallel testing of compounds, either small molecules or biologics, on a large panel of human cancer cell lines. We use […]
New insights into the targeting of amino acid-metabolizing enzymes for cancer immunotherapy
Over the recent decades, cancer immunotherapy has emerged as a revolutionary approach to reinvigorate host anti-tumor immunity. However, while immune checkpoint inhibitors have proven […]
Expansion of ResidenceTimer™ kinase panel
Determination of target residence time may help you to differentiate your drug candidate from competitor compounds. Drugs that reside on their target for several […]
Compound profiling on EGFR mutants and osimertinib-resistant cell lines
Mutations in the epidermal growth factor receptor (EGFR) are the most common oncogenic drivers in non-small cell lung cancer (NSCLC), but many patients treated […]
Premium Benefits of Oncolines Precision Medicine Services: Cell-Based Assays, Drug Combinations, High-Throughput Screening